[Hemofiltration (HF) and hemodiafiltration (HDF)--overview].
Isakozawa
Yutaka
Y
Department of Clinical Engineering, Faculty of Medical Engineering, Suzuka University of Medical Science.
Takesawa
Shingo
S
D000686:Amyloidosis / Q000209:etiology / Q000628:therapy; D003404:Creatinine / Q000302:isolation & purification; D015314:Dialysis Solutions / Q000737:chemistry / Q000592:standards; D004731:Endotoxins / Q000302:isolation & purification; D017583:Hemodiafiltration / Q000379:methods; D006440:Hemofiltration; D006801:Humans; D006435:Renal Dialysis / Q000009:adverse effects; D014508:Urea / Q000302:isolation & purification; D001613:beta 2-Microglobulin / Q000302:isolation & purification
D015314:Dialysis Solutions; D004731:Endotoxins; D001613:beta 2-Microglobulin; D014508:Urea; D003404:Creatinine